CPPI CV
SpecialtyCPPI CV is a specialty pharmaceutical company focused on Oncology, Gastroenterology.
CPPI CV's Key Drugs
CPPI CV's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
CPPI CV's Recent FDA Approvals
New NDA/BLA approvals for CPPI CV over the last two years — novel drugs only, excluding generics and label supplements.
CPPI CV's Therapeutic Areas
CPPI CV's approved drugs and pipeline span 2 therapeutic areas, led by Oncology and Gastroenterology, across 0 biologic and 1 small-molecule drug. Weighted by commercial stage — approved drugs count most, then late-stage trials.
CPPI CV's Top Competitors
CPPI CV's closest competitors by therapeutic-area and drug-target overlap include Johnson & Johnson, Bristol-Myers Squibb, and Takeda. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
CPPI CV Pipeline Snapshot
Active clinical trials for CPPI CV across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Oncology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2006-01-26
- Latest
- 2021-08-30
- Applications
- 2